CANCER PATHWAY ERK_MEK & PI3K_AKT.xpn

Name: CANCER PATHWAY ERK_MEK & PI3K_AKT.xpn
Creator: MDPI
Published: 2026-02-03T11:10:26+08:00

Zenodo2026-02-03 更新2026-05-26 收录

癌症信号通路

生物网络计算分析

数据链接：

https://zenodo.org/doi/10.5281/zenodo.18467372 数据链接链接失效反馈

官方服务：

资源简介：

This supplementary data contains Petri net model of the integrated MAPK-PI3K/Ark network developed in Snoopy tool and P-invariants and T-invariants calculated in Charlie tool.

提供机构：

MDPI

创建时间：

2026-02-03

ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis [ChIP-seq]

癌症分子机制

癌症信号通路

Lung cancer remains the leading cause of cancer death. Genome sequencing of lung tumors from patients with Squamous Cell Carcinoma has identified SMAD4 to be frequently mutated. Here we used a novel m

NIAID Data Ecosystem90

Additional file 4: of Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals

癌症生物标志物

癌症信号通路

Table S4. miR-452-5p expression in RCC and normal renal samples from TCGA RCCÂ dataset. (XLS 137Â kb)

NIAID Data Ecosystem60

Polyomavirus middle-sized tumor antigen modulates c-Jun phosphorylation and transcriptional activity.

癌症信号通路

转录因子调控

Polyomavirus middle-sized tumor antigen (MT) increases the expression of c-jun through a phorbol 12-O-tetradecanoate 13-acetate response element in the c-jun promoter. To investigate the cellular sign

PubMed Central1994-10-11 更新20

Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters

磷酸化蛋白质组学

癌症信号通路

Phosphorylation is a major post-translational modification that regulates protein function, with phosphotyrosine (pY) modifications being implicated in oncogenesis. However, global profiling of pY sta

NIAID Data Ecosystem60

Pancreatic cells are resistant to KRASQ61L expression due to hyperactivation of ERK/MAPK signaling and induction of apoptosis

癌症信号通路

KRAS突变研究

The RAS family of small GTPases is among the most frequently mutated gene families in human cancer. In pancreatic ductal adenocarcinoma (PDAC), ~95% of cases harbor an activating KRAS mutation, primar

NIAID Data Ecosystem40

CANCER PATHWAY ERK_MEK & PI3K_AKT.xpn

资源简介：

相关数据集